A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies

Published:2015-05-13 Issue:24 Volume:34 Page:3194-3213
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Hirakawa Akihiro¹,Wages Nolan A.²,Sato Hiroyuki³,Matsui Shigeyuki⁴

Affiliation:

1. Center for Advanced Medicine and Clinical Research; Nagoya University Graduate School of Medicine; Nagoya 466-8550 Japan

2. Department of Public Health Sciences; University of Virginia; Charlottesville 22904 Virginia U.S.A.

3. Biostatistics Group, Office of New Drug V; Pharmaceuticals and Medical Devices Agency; Tokyo 100-0013 Japan

4. Department of Biostatistics; Nagoya University Graduate School of Medicine; Nagoya 466-8550 Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference36 articles.

1. Continual reassessment method: a practical design for phase I clinical trials in cancer;O'Quigley;Biometrics,1990

2. Adaptive designs for dual-agent phase I dose-escalation studies;Harrington;Nature Reviews Clinical Oncology,2013

3. A non-parametric approach to the design and analysis of two-dimensional dose-finding trials;Ivanova;Statistics in Medicine,2004

4. Design issues in dose-finding phase I trials for combinations of two agents;Fan;Journal of Biopharmaceutical Statistics,2009

5. A two-dimensional search algorithm for dose-finding trials of two agents;Lee;Journal of Biopharmaceutical Statistics,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new function for drug combination dose finding trials;Scientific Reports;2024-02-12

2. A comparison of model-free phase I dose escalation designs for dual-agent combination therapies;Statistical Methods in Medical Research;2024-01-24

3. Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes;Statistics in Biopharmaceutical Research;2023-11-28

4. Isotonic design for phase I cancer clinical trials with late-onset toxicities;Journal of Biopharmaceutical Statistics;2023-01-06

5. Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial;Statistics in Medicine;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3